LT Foods Q1: revenue +28% YoY, EBITDA margin widens; consol PAT +9% to ₹183 Cr
PAT +8.9% YoY · revenue +27.9% · margins expanding
₹3,151.83 Cr
+27.9% YoY
₹183.45 Cr
+8.9% YoY
5.8%
-0.9pp YoY
₹5.28
LT Foods opened FY27 with its strongest topline print yet: consolidated revenue rose 27.9% YoY to ₹3,151.8 Cr (up 8.4% QoQ) and operating (EBITDA) margin expanded to ~11.2% from 10.8% a year ago and 9.3% last quarter — the recovery management had guided toward as U.S. tariff and brand-investment drags normalise. Reported consolidated PAT, however, grew only 8.9% YoY to ₹183.4 Cr (EPS ₹5.28), well behind revenue. The gap is entirely non-operating: other income collapsed to ₹9.5 Cr from ₹37.1 Cr a year ago, finance costs climbed to ₹40.3 Cr (from ₹28.0 Cr) on a larger working-capital base, depreciation rose to ₹74.1 Cr, and the associate/JV contribution shrank to ₹0.9 Cr from ₹6.2 Cr. Net margin therefore compressed to 5.8% YoY (from 6.7%) even as the core business margin improved — so this is an operating beat with a non-operating drag, not an earnings slowdown.
Q1 FY-2027 vs prior quarters
The 35% QoQ jump in PAT flatters the print and should be read cautiously: Q4 FY26 carried an inventory build (changes in inventories were a large negative), so the sequential bounce is partly a base effect rather than a fresh acceleration. On a YoY basis — the fairer lens — the operating engine did the work: revenue up nearly 28% against management's long-term 10-12% growth frame, with the RTH/branded push and global demand driving volume. Standalone tells a softer story (revenue ₹1,172.1 Cr, PAT ₹70.2 Cr), with the export/subsidiary layer carrying the growth; the auditor flags eleven unreviewed subsidiaries running a combined ₹19.4 Cr net loss for the quarter, a reminder the consolidated margin is still absorbing overseas start-up/tariff costs.
The stock went into the print at ₹386.05, up 2.9% over the past month of trading.
For context: this is the highest quarterly PAT in the last 6 quarters on our records; revenue is at a 6-quarter high.
Management guides for continued double-digit revenue growth in the 10-12% range for the long term, driven by global demand and expansion. EBITDA margins are expected to gradually recover to the 12% level as one-off impacts like the U.S. tariff normalize and strategic brand investments stabilize. Capex is projected to r
— This quarter: met
Against prior guidance the quarter is on track: revenue is comfortably ahead of the 10-12% frame and OPM is climbing toward the promised ~12%, though not there yet. Corporate activity this quarter was expansion-led — a new wholly owned Australian subsidiary (LT Foods Australia PTY, incorporated June 23, 2026) and the DAAWAT World Biryani Day brand push — consistent with the capex-heavy, Ready-to-Heat-led strategy where new capacity is slated to come online in Q2 FY27. The Ecopure U.S. countervailing-duty matter (rate cut to 75.48% from 340.27%, under appeal with a CIT injunction) and the ₹134.1 Cr Daawat Foods insurance claim remain open but carry no P&L impact this quarter.
W1
OPM trajectory toward the guided ~12% — held at ~11.2% this quarter; watch whether Ready-to-Heat capacity coming online in Q2 FY27 lifts it
W2
Other income and finance-cost normalisation — other income at ₹9.5 Cr (vs ₹37.1 Cr YoY) and finance costs ₹40.3 Cr suppressed net-margin conversion
W3
Ecopure US countervailing-duty appeal (75.48% rate) and eleven overseas subsidiaries running a combined ₹19.4 Cr net loss this quarter
Machine-readable statement, unit Lakhs, converted to Cr. Consol PBT includes ₹0.90 Cr associate/JV profit (₹6.17 Cr year-ago); no NCI. No P&L exceptional items — insurance claim (₹134.1 Cr) held off-P&L as liability; Ecopure US CVD (75.48%) not provided for.
Growth inflated by tariffs, margins miss guidance
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Beat revenue guidance but margin target missed (12% → 11.2%). Tariff and organic headwinds acknowledged; organic restructuring reset realistic but will weigh FY27.
Optimistic
next 1–2 quarters
Optimistic
multi-year
Strong top-line beat (27.9% YoY) overwhelmed by tariff relief and commodity inflation; underlying volume growth only 11%, profit growth soft at 8.9%. EBITDA margins missed 12% guidance target at 11.2%, compressing YoY. India remains solid foundation but margin recovery story derailed by organic drag and geopolitical freight spikes. Execution intact but growth quality weak.
₹3151.8 Cr
Revenue · +27.9% YoY₹183.4 Cr
Reported PAT · +8.9% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
achieved 26.4% year-on-year growth despite challenging environment
MET27.9% YoY revenue growth; volume growth only 11% for basmati — tariff reduction (50%→10%) and commodity inflation drove 70%+ of gain
EBITDA grew by 20% to ₹363 crores; profitability remained healthy
OVERSTATEDEBITDA likely ~₹363 Cr; OPM 11.2%, down from prior ~12.1%. Margin compression vs prior quarter despite revenue beat.
results in line with annual estimates; on track for full year across all financial parameters
MISSRevenue tracking well, but EBITDA margin target of 12% missed at 11.2–11.5%. Guidance contingent on tariff normalization and geopolitical stabilization.
India market share reached 23.1%; household penetration 64.4 lakh
METMarket share 23.1% (down from 23.7% in FY26 per analyst data). Household penetration up 20 lakh YoY — growth real, but share narrative softened by Nielsen reset claim.
U.S. basmati import share now more than 60%; growing faster than category
PartialMarket dominance validated. Volume growth lower (27% normalized) than headline growth due to tariff and commodity mix — pricing, not volume, drove headline
Earnings quality
What changed since the last call
Margin guidance effectively cut
DowngradePrior target 12% EBITDA recovery now at 11.2–11.5%. Organic restructuring cost and tariff benefit normalization imply margins stay under pressure through FY27.
Organic restructuring extended timeline
DowngradeOrganic EBITDA margin 4% vs prior double-digit; now expect 1.5 years (by FY27-28) to return to double-digit, not this year.
RTH ramp extended to 2–3 years
NeutralRTH breakeven at ₹400 Cr revenue (2–3 years); new U.S. facility operationalizing Q1, expected to accelerate but path remains long.
Tariff credit not yet booked
WithdrawnManagement stated eligible for U.S. duty refunds but 'have not booked any income yet, in talk with customers' — upside contingent, not assured.
Core basmati guidance maintained
Neutral10–12% long-term growth reiterated; normalized growth 19% this quarter (excl. tariff/inflation) suggests underlying 10–12% sustainable but near-term tailwinds temporary.
The Q&A
Moderate. Analysts pressed on market share decline (Nielsen reset cited), organic margin collapse (restructuring acknowledged with timeline), tariff sustainability (framed temporary), and U.S. discount pass-through (netted off). Management held firm; no evasion but some defensiveness on market share narrative.
El Niño crop impact — Avnish Roy, Nuvama
Answered80–85% basmati is irrigated (canal/groundwater), 14–15% rain-dependent. Historical data shows limited red alert; by mid-August will have clarity. Confident on passing inflation to consumer historically.
India market competition — Avnish Roy, Nuvama
AnsweredFocus on market creation, shift loose to branded basmati. Gained share last quarter. Launched I'm Organic in Daawat e-comm. Charging premium vs competitors.
U.S. business dynamics — Bhavi Chauhan, Care PMS
AnsweredSales recorded at net basis; promotions netted off per accounting. Golden Star consolidation this quarter drove normalization vs prior year.
Organic restructuring timeline — Praveen Kumar, Acuitas Capital
AnsweredChanged from wholesale to CPG, infrastructure set. Expect 1.5 years for gradual improvement. By FY27-end, EBITDA ₹70–80 Cr (currently 4%).
RTH breakeven path — Unni, Geojit Investments
AnsweredBreakeven at ₹400 Cr revenue, 2–3 years. New U.S. facility coming online. On track despite near-term margin pressure.
Middle East market strategy — Abhishek Mathur, Systematix Group
AnsweredCore business, will remain. Play premium/mid-segment, not lower. Growth 15% range. Distributor and direct mix by country.
Supplier financing impact — Bhavi Chauhan, Care PMS
AnsweredAt optimum supplier funding level. 4–5 days legroom possible but not major further reduction.
Market share decline (India) — Nan, Marcellus Investment Managers
PartialNielsen reset methodology 2–3 years ago; this quarter improved. Strong #1 position in core states (MH, Gujarat, MP). 40%+ e-commerce share, +20 lakh household penetration.
Tariff credit eligibility — K B Sankara Rao, Individual Investor
DodgedEligible; partly received Q1. Not yet booked income; in talks with customers.
Basmati volume vs revenue bridge — Anubhav Mukherjee, Prescient Capital
AnsweredInflation in commodity passed on + tariff (10% U.S. duty).
Jasmine vs basmati growth rates — Saurabh Beria, Sameeksha Capital
AnsweredBoth 5–10% growth range; Jasmine slightly faster. Jasmine 3x larger market. Basmati has higher EBITDA margin, Jasmine higher ROIC (120-day WC vs longer).
Guidance
Core basmati 10–12% long-term growth; RTH 15–20% from small base
MediumNormalized growth 19% this quarter suggests tariff/inflation boosted headline; underlying organic 10–12% realistic but cyclical
Organic double-digit growth by FY27-28 (1.5 years)
LowCurrent negative trajectory; requires successful CPG ramp in Europe, U.S. to accelerate from ₹254 Cr baseline
RTH to double revenue in 3 years from Q1 base
MediumU.S. facility operationalization key; breakeven ₹400 Cr revenue in 2–3 years; currently ~₹50 Cr run-rate suggests 8x growth needed
Middle East 15% growth (acknowledged saturated market, niche play)
LowSmall base, freight volatility risk; premium/mid-segment focus limits upside
Basmati EBITDA margin ~13–14% sustainable
HighStable at 13% this quarter despite tariff/freight headwinds; management confident on pricing power
Consolidated EBITDA margin gradual recovery to 12% (prior stated)
LowCame in 11.2–11.5% this quarter, down from 12.1% prior. Organic 4% drag will persist 1–1.5 years
Organic EBITDA margin to double-digit by FY27-28
LowCurrently 4%; path requires 3–4x improvement over 1.5 years; restructuring execution risk
Prior guidance ~₹350 Cr annually for capacity expansion (RTH, organic, global)
MediumDoubled RTH capacity, expanded European organic facilities. No explicit FY27 capex guide given this call; ROCE 21.1% suggests disciplined spend
Risks the call surfaced
Tariff & commodity cycle
HighTariff benefit (50%→10% U.S.) and commodity inflation accounted for ~70% of Q1 growth; normalized underlying growth only 10–12%. Tariff normalization in H2/FY28 will reverse pricing gain; basmati volume (11% YoY) insufficient to offset.
Geopolitical logistics
MediumMiddle East freight ₹200→₹4,000/container; Europe/UK logistics 4.7% of revenue. Competitive intensity in ME prevents pass-through; margins turning negative in geography. Unresolved shipping disruptions.
Organic segment execution
HighOrganic EBITDA margin collapsed to 4% from prior 35%+ due to CPG wholesale-to-direct shift and European capacity expansion. Guidance ₹70–80 Cr EBITDA by FY27-end (from ~₹10 Cr now) requires 7–8x improvement. 1.5-year recovery timeline extends into FY27-28.
RTH path to profitability
MediumRTH (ready-to-heat/cook) growing 13% YoY but EBITDA margin declining. Breakeven at ₹400 Cr revenue in 2–3 years; current run-rate ~₹50 Cr implies 8x growth needed. New U.S. facility operationalization key catalyst; delays would extend timeline and burn cash.
India market share erosion
LowMarket share 23.1% (down from 23.7% FY26 per analyst question). Management attributes to Nielsen methodology reset; claims market creation focus and share gain this quarter. But segment growth slowing as competitors ramp.
Management
Score 7/10. Direct and quantitative; management provides detailed geographic and segment color, acknowledges headwinds transparently (tariff, freight, organic drag). Willing to take hard questions; no major evasions noted except tariff credit timing ('not yet booked income, in talks with customers'). Mixed. Core basmati and India business tracking well (volume +11%, market penetration +20 lakh, ROCE 21.1%). Working capital optimized. But organic restructuring underperforming (margin 4% vs target), RTH still unprofitable (2–3 years to breakeven), and tariff/freight headwinds hitting consolidated margins (OPM down 90bps). On-plan vs prior year but facing near-term pressure.
1 · Aug 2026
El Niño crop yield impact clarity; basmati sourcing cost path
2 · Q2 FY27
U.S. RTH facility operationalization; capacity ramp to accelerate growth
3 · H2 FY27
Tariff normalization; underlying margin recovery if freight stabilizes
Execution intact but growth quality weak.
Revenue surges 27.9%, but profit growth stalls at 8.9%—EBITDA margin target missed
Headline revenue beat is powered by tariff relief and commodity inflation, not volume. Underlying growth of just 11% and a margin miss on guidance expose the quality gap.
₹3,152 Cr
+27.9% YoY; strong headline
+8.9%
PAT ₹183 Cr; 3.1× gap vs revenue
11.2%
OPM down 90bps; target was 12%
+11%
Basmati organic; headline inflated by tariff
Q1 delivered a headline beat on revenue—₹3,152 crore, up 27.9% year-on-year—but a profit growth slowdown and margin miss expose the underlying weakness. PAT climbed just 8.9%, and operating margins fell to 11.2%, missing the company's 12% guidance target. The gap between the top-line pop and the earnings lag is the story of the quarter.
Where the headline growth came from
Of the 27.9% revenue jump, management's own Q&A reveals that roughly 70% was tariff-driven and commodity inflation; underlying basmati volume growth was only 11%. The headline was boosted by a 50% to 10% tariff drop in the U.S. and the pass-through of commodity cost inflation to customers. As tariff benefits normalize in H2 FY27 and inflation cycles, that pricing tailwind reverses—leaving the company leaning on 11% volume growth to sustain long-term momentum.
Achieved 26.4% growth despite challenging environment
27.9% YoY, but 70% driven by tariff (50%→10%) and commodity inflation; volume +11%
Supported (quality soft)
EBITDA grew 20%, profitability remained healthy
EBITDA ~₹363 Cr; OPM 11.2%, down 90bps YoY; missed 12% target
Overstated
Results in line with estimates, on track full-year
Revenue tracking, EBITDA margin 12% target missed at 11.2–11.5%
Contradicted
Market share 23.1%, household penetration 64.4 lakh
Share flat (23.7% FY26 → 23.1% Q1); penetration +20 lakh YoY real
Supported
What changed on this call
Management effectively cut the EBITDA margin guidance by missing the 12% target (came in 11.2–11.5%). The organic restructuring—a shift from wholesale to CPG distribution and European facility expansion—is now acknowledged to weigh for 1.5 years (not this year), with EBITDA margin at just 4% today vs. prior double-digit levels. RTH (ready-to-heat/cook) breakeven pushed to 2–3 years at ₹400 crore revenue. The tariff credit upside—eligible for U.S. court duty refunds—remains unbooked, 'in talks with customers.' Core basmati guidance of 10–12% long-term growth was reiterated, but the company is now clearly guiding for tariff normalization to drag near-term growth.
Basmati volume +11% on track; pricing power demonstrated (commodity inflation passed on)
India household penetration +20 lakh; market leadership in core states (Maharashtra, Gujarat, MP)
U.S. basmati import share >60%; category leadership validated
Working capital cycle improved 25 days; ROCE 21.1% maintained
Headline 27.9% revenue growth inflated by tariff (50%→10%) and commodity inflation; 70% non-recurring
EBITDA margin missed 12% target, came in 11.2%; OPM -90bps, NPM -140bps YoY
Organic EBITDA margin 4%; recovery to ₹70–80 Cr by FY27-end requires 7–8× improvement
Middle East freight spike (₹200→₹4,000 per container) unpassable in competitive market; geography turned negative
RTH unprofitable; 2–3 year path to ₹400 Cr breakeven; operationalization risk
Market share flat (23.1% vs 23.7% prior); third-player entry fragmenting gains
Tariff normalization reversal
High70% of Q1 revenue growth is tariff-driven; normalization in H2 FY27/FY28 will deflate headline growth back to ~11% organic. Volume growth insufficient to sustain 27.9% without tariff tailwind.
Margin recovery delayed
HighOPM target 12% missed at 11.2%; consolidated margin under pressure from organic 4% drag for 1.5 years. Credibility gap between guidance and delivery widens if restructuring slips.
Organic restructuring execution
HighCPG distribution shift and European capacity expansion at critical stage; ₹70–80 Cr EBITDA target by FY27-end requires 7–8× improvement from ₹10 Cr today. Failure extends timeline 2+ years and burns cash.
Geopolitical freight volatility
MediumMiddle East freight ₹200→₹4,000; Europe/UK logistics 4.7% of revenue. Competitive intensity prevents pass-through; margin compression unresolved until shipping normalizes.
RTH path to profitability
Medium2–3 years to ₹400 Cr breakeven revenue. New U.S. facility operationalization key; delays or underutilization extend timeline and defer returns.
India market share erosion
LowMarket share 23.1% vs 23.7% prior year; third-player entry (Fortune, Kohinoor) fragmenting. Defended by Nielsen reset narrative but share gains momentum slowing.
How the street is positioned
The market initially rewarded the print—up 3.34% on day 1, then +5.11% by day 3 (delivery 51.5%), confirming the pop held and wasn't a short-squeeze fade. But FII flows are tightening (down 18 basis points QoQ to 8.74%), suggesting institutional buyers are becoming cautious on margin quality despite the revenue beat. The stock is trading at ₹417.4, down 11.37% from its all-time high of ₹470.95 but above its 20-day (₹386.73), 50-day (₹384.6), and 200-day (₹395.98) moving averages—a modestly overbought technical (RSI 69.6) sitting on a pullback from ATH. The drawdown is not yet punitive, but FII trimming suggests the market is pricing in near-term headwinds (tariff normalization, organic drag) even as it respects the core basmati strength.
1 · El Niño crop clarity (Aug 2026)
Irrigation cost and basmati sourcing cost path; management 80–85% of basmati is irrigated (low risk), but mid-August clarity needed.
2 · U.S. RTH facility operationalization (Q2 FY27)
Expected online this quarter; capacity ramp to accelerate growth and shorten path to ₹400 Cr breakeven. Delays would undermine narrative.
3 · Tariff normalization timeline (H2 FY27 / FY28)
When will tariff benefits (50%→10%) fade? How much of headline growth will stick as organic 11%? This is the linchpin of the year-ahead narrative.
4 · Organic EBITDA trajectory (FY27-end target ₹70–80 Cr)
Progress on CPG distribution ramp and European facility absorption. On pace for ₹70–80 Cr or reset coming? Restructuring risk contained vs. extended.
5 · Geopolitical freight stabilization
Middle East (₹200→₹4,000 per container) and Europe/UK logistics cost path. Margin recovery contingent on shipping normalization; unresolved carries downside.
LT Foods is not a broken franchise—basmati execution is solid, India penetration is real, U.S. dominance is validated. But this quarter is a tale of two lenses. The headline tells one story (27.9% growth); the earnings quality tells another (70% tariff-driven, underlying 11%, margins miss guidance).
Holders should expect steady execution going forward, not a step-change. The number to track from here is the organic EBITDA trajectory—if the company is on pace to reach ₹70–80 crore by FY27-end, restructuring risk is contained; if it slips, consensus will have to reset expectations and the margin recovery story unravels.
Near term, watch tariff normalization. Until it reverses, don't mistake tailwinds for tailwind-free growth.